Kamil Wisniewski

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Correction for: Accelerated chronic lymphocytic leukemia - characteristics and retrospective analysis of the Polish Adult Leukemia Study Group.

Correction for: Accelerated chronic lymphocytic leukemia - characteristics and retrospective analysis of the Polish Adult Leukemia Study Group.

Journal: Contemporary oncology (Poznan, Poland)
Published: October 16, 2025

Daratumumab or active observation for asymptomatic biochemical relapse in patients with multiple myeloma.

Daratumumab or active observation for asymptomatic biochemical relapse in patients with multiple myeloma.

Journal: British journal of haematology
Published: October 09, 2025

Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL - real-life data analysis of the Polish Adult leukemia group.

Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL - real-life data analysis of the Polish Adult leukemia group.

Journal: Leukemia & lymphoma
Published: August 01, 2025

Accelerated chronic lymphocytic leukemia - characteristics and retrospective analysis of the Polish Adult Leukemia Study Group.

Accelerated chronic lymphocytic leukemia - characteristics and retrospective analysis of the Polish Adult Leukemia Study Group.

Journal: Contemporary oncology (Poznan, Poland)
Published: January 13, 2025

A Review of Resistance Mechanisms to Bruton's Kinase Inhibitors in Chronic Lymphocytic Leukemia.

A Review of Resistance Mechanisms to Bruton's Kinase Inhibitors in Chronic Lymphocytic Leukemia.

Journal: International journal of molecular sciences
Published: March 31, 2024

Real-World Outcome and Prognostic Factors in MDS Patients Treated with Azacitidine-A Retrospective Analysis.

Real-World Outcome and Prognostic Factors in MDS Patients Treated with Azacitidine-A Retrospective Analysis.

Journal: Cancers
Published: March 03, 2024

The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age.

The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age.

Journal: Cancers
Published: May 30, 2023

Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia.

Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia.

Journal: Cancers
Published: December 30, 2021

Rituximab and Chemotherapy for Newly Diagnosed Follicular Lymphoma: Real-World Report of Polish Lymphoma Research Group.

Rituximab and Chemotherapy for Newly Diagnosed Follicular Lymphoma: Real-World Report of Polish Lymphoma Research Group.

Journal: Chemotherapy
Published: November 03, 2021

Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia.

Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia.

Journal: Cancer management and research
Published: January 17, 2020
Showing 1-10 of 10

Last Updated: 09/26/2026